Weight Loss Goals This study shows that GLP-1 users lose 5-15% of body weight over a one-year period
It inhibits key molecules that play a role in inflammation, including TNF-, IL-1, and IL-6, mainly through the inhibition of the NF-kB pathway, which is a critical regulator of the immune response and inflammation
Results from the PIONEER PLUS and OASIS trials showed that Rybelsus, an oral version of semaglutide, is effective for treating type 2 diabetes and overweight or obesity at high doses
I married the kind of woman that makes you smile when you cry
With Indias rapidly growing diabetic population and rising awareness of obesity, GLP-1 therapies present a significant growth opportunity.Eris has established a strong presence in diabetology through deep engagement with specialists across India
Microglia and neuroinflammation: crucial pathological mechanisms in traumatic brain injury-induced neurodegeneration